The Gujarat High Court clarified that trademark infringement requires a holistic comparison of marks and their respective goods or services. The court found no likelihood of confusion between…
Dr. Kalyan Kankanala · 13 Aug 2024
The Bombay High Court vacated an ex-parte injunction in a trademark dispute due to Atyati's suppression of material facts regarding Cognizant's prior logo use. This decision reiterates the…
Intellepedia · 12 Aug 2024
The Bombay High Court granted Novartis an injunction against Novarish Healthcare for trademark infringement and passing off. The court found the marks deceptively similar and protected Novartis's established…
Intellepedia · 7 Aug 2024
The Delhi High Court granted an injunction against Qpharm for using deceptively similar packaging and trade dress to Glaxo’s products. This case illustrates the enforcement of trade dress…
Intellepedia · 1 Aug 2024
The Calcutta High Court quashed a Registrar’s order granting North-Western a trademark with an elephant device, favouring Girnar’s prior rights. The judgment clarifies the assessment of prominent features…
Intellepedia · 25 Jul 2024
The Delhi High Court has blocked fraudulent websites infringing on the Ginger Hotel brand and ordered banks to freeze associated accounts. This protects IHCL’s trademark rights and safeguards…
Intellepedia · 18 Jul 2024
The Delhi High Court granted a permanent injunction to Heifer Project International over unauthorized use of its trademarks by Heifer Project India Trust. The Court’s decision highlights the…
Intellepedia · 16 Jul 2024
The Delhi High Court dismissed Relaxo Footwear’s claim over the 'X' device mark against XS Brands, highlighting the significance of coexistence and lack of confusion in trademark disputes.…
Intellepedia · 8 Jul 2024
The Madras High Court granted MRF a permanent injunction and nominal damages against Powermax for trademark and copyright infringement. The judgment underscores the legal significance of safeguarding established…
Intellepedia · 1 Jul 2024
The Bombay High Court has restrained Gleck Pharma from using XIGAMET for its diabetes product, finding it deceptively similar to Glenmark’s ZITA-MET. This decision highlights the Court’s heightened…
Dr. Kalyan Kankanala · 25 Jun 2024